ASKA technology-based pull-down method reveals a suppressive effect of ASK1 on the inflammatory NOD-RIPK2 pathway in brown adipocytes

Sci Rep. 2021 Nov 10;11(1):22009. doi: 10.1038/s41598-021-01123-7.

Abstract

Recent studies have shown that adipose tissue is an immunological organ. While inflammation in energy-storing white adipose tissues has been the focus of intense research, the regulatory mechanisms of inflammation in heat-producing brown adipose tissues remain largely unknown. We previously identified apoptosis signal-regulating kinase 1 (ASK1) as a critical regulator of brown adipocyte maturation; the PKA-ASK1-p38 axis facilitates uncoupling protein 1 (UCP1) induction cell-autonomously. Here, we show that ASK1 suppresses an innate immune pathway and contributes to maintenance of brown adipocytes. We report a novel chemical pull-down method for endogenous kinases using analog sensitive kinase allele (ASKA) technology and identify an ASK1 interactor in brown adipocytes, receptor-interacting serine/threonine-protein kinase 2 (RIPK2). ASK1 disrupts the RIPK2 signaling complex and inhibits the NOD-RIPK2 pathway to downregulate the production of inflammatory cytokines. As a potential biological significance, an in vitro model for intercellular regulation suggests that ASK1 facilitates the expression of UCP1 through the suppression of inflammatory cytokine production. In parallel to our previous report on the PKA-ASK1-p38 axis, our work raises the possibility of an auxiliary role of ASK1 in brown adipocyte maintenance through neutralizing the thermogenesis-suppressive effect of the NOD-RIPK2 pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes, Brown / drug effects
  • Adipocytes, Brown / metabolism*
  • Adipocytes, White / metabolism
  • Animals
  • Cytokines / analysis
  • HEK293 Cells
  • Humans
  • Inflammation / drug therapy
  • MAP Kinase Kinase Kinase 5 / pharmacology*
  • Mice
  • Nod Signaling Adaptor Proteins / drug effects*
  • Receptor-Interacting Protein Serine-Threonine Kinase 2 / drug effects*
  • Receptor-Interacting Protein Serine-Threonine Kinase 2 / metabolism
  • Signal Transduction / drug effects
  • Uncoupling Protein 1 / drug effects

Substances

  • Cytokines
  • Nod Signaling Adaptor Proteins
  • Uncoupling Protein 1
  • Receptor-Interacting Protein Serine-Threonine Kinase 2
  • MAP Kinase Kinase Kinase 5